REBOA在破裂腹主动脉瘤杂交手术中改善结局
回顾性分析2014年1月至2021年11月53例因破裂腹主动脉瘤行急诊开放主动脉手术的患者,比较REBOA组(21例)与非REBOA组(32例)。REBOA组24小时死亡率(9.5% vs 37.5%,P=0.029)和30天死亡率(14.2% vs 43.7%,P=0.035)均显著低于非REBOA组,住院时间和ICU时间更短,并发症率无显著差异。作者认为REBOA可考虑作为rAAA开放手术的一线治疗选择。
要点
- REBOA组24小时死亡率9.5% vs 非REBOA组37.5%,P=0.029
- REBOA组30天死亡率14.2% vs 非REBOA组43.7%,P=0.035
- REBOA组住院时间12.8±3.48天 vs 非REBOA组15.6±4.74天,P=0.02
核心结论
- REBOA组较非REBOA组生存率显著改善,并发症率无显著差异。
- 作者认为REBOA与传统开放主动脉阻断相比创伤更小。
- 作者认为在rAAA开放手术中,尤其当成品血管腔内动脉瘤修复装置不适用时,REBOA可考虑作为一线治疗选择。
研究设计与样本
- 回顾性分析2014年1月至2021年11月连续53例因rAAA行急诊开放主动脉手术的患者。
- 患者分为REBOA组(21例)和非REBOA组(32例)。
- 共46例男性、7例女性,平均年龄71.9±7.9岁,范围51-89岁。
主要发现
- REBOA组24小时死亡率9.5% vs 非REBOA组37.5%,P=0.029。
- REBOA组30天死亡率14.2% vs 非REBOA组43.7%,P=0.035。
- REBOA组住院时间12.8±3.48天 vs 非REBOA组15.6±4.74天,P=0.02。
- REBOA组ICU停留时间2.42±2.08天 vs 非REBOA组5.09±5.79天,P=0.048。
- REBOA组总手术时间和出血减少,术后肾衰竭、肠缺血和TIA/卒中率无显著差异。
临床怎么用
- 作者认为REBOA可考虑作为rAAA开放手术的一线治疗选择,尤其当成品血管腔内动脉瘤修复装置不适用时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advancements in diagnostic methods and emergency interventions, mortality rates of ruptured abdominal aortic aneurysm (rAAA) continue to remain high. To address this issue, the resuscitative endovascular balloon occlusion of the aorta (REBOA) technique has been designed to provide temporary control of bleeding. We aimed to compare the impact of the REBOA technique during open aortic surgery for rAAA. METHODS: Between January 2014 and November 2021, 53 consecutive patients (46 males, 7 females; mean age 71.9 ± 7.9 years; range 51-89 years) who underwent emergency open aortic surgery for rAAA were retrospectively analyzed. Patients were divided into REBOA (21 patients) and non-REBOA (32 patients) groups. The primary outcomes were postoperative 24-hr and 30-day mortality. The secondary outcomes were intensive care unit (ICU) stay, in-hospital stay, bleeding, postoperative renal failure, bowel ischemia, and transient ischemic attack (TIA)/stroke rate. RESULTS: The REBOA group showed a significant reduction in mortality rates at both 24 hr (9.5% vs. 37.5%, P = 0.029) and 30 days (14.2% vs. 43.7%, P = 0.035) compared to the non-REBOA group. In-hospital stay (12.8 ± 3.48 vs. 15.6 ± 4.74 days, P = 0.02) and ICU stay (2.42 ± 2.08 vs. 5.09 ± 5.79 days, P = 0.048) were shorter among the REBOA group. Total procedure time and bleeding were reduced among the REBOA group without significant differences in terms of postoperative renal failure, bowel ischemia, and TIA/stroke rate. CONCLUSIONS: The REBOA group demonstrated significantly improved survival rates compared to the non-REBOA group, without a significant difference in complication rates. REBOA is considered a less invasive option compared to the traditional method for open aortic cross-clamping. This study demonstrated that the use of REBOA may be considered as a first-line treatment option for open surgery in cases of rAAA particularly when an off-the-shelf endovascular aneurysm repair device is not suitable.
引用
- Deser SB, Arapi B, Tel Ustunisik C, et al. REBOA Improves Outcomes in Hybrid Surgery for Ruptured Abdominal Aortic Aneurysms. Ann Vasc Surg. 2023. PMID: 38122969. doi:10.1016/j.avsg.2023.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。